Skip to main content

Raplon Side Effects

Generic name: rapacuronium

Note: This document provides detailed information about Raplon.

Applies to rapacuronium: intravenous powder for injection Side Effects associated with rapacuronium. Some dosage forms listed on this page may not apply specifically to the brand name Raplon.

Applies to rapacuronium: intravenous powder for injection.

Cardiovascular adverse events

Cardiovascular effects including hypotension (5.2%), tachycardia (3.2%), and bradycardia (1.5%) have been reported.[Ref]

Respiratory

Respiratory effect including bronchospasm (3.2%) have been reported.[Ref]

References

1. (2001) "Product Information. Raplon (rapacuronium)." Organon

2. Goudsouzian NG (2001) "Rapacuronium and bronchospasm." Anesthesiology, 94, p. 727-8

3. Kron SS (2001) "Severe bronchospasm and desaturation in a child associated with rapacuronium." Anesthesiology, 94, p. 923-4

4. Naguib M (2001) "How serious is the bronchospasm induced by rapacuronium?." Anesthesiology, 94, p. 924-5

5. Meakin GH, Pronske EH, Lerman J, Orr R, Joffe D, Savaree AM, Lynn AM (2001) "Bronchospasm after rapacuronium in infants and children." Anesthesiology, 94, p. 926-7

Further information

Raplon side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.